If you looking good of the company prospect just buy and hold it waiting big wave come and surf together. If not please leaving the counter and keep your money to buy real toilet paper at supermarket. Haha...
someone posted in KLSE Screener forum that XDL got vaccine distributed project, something similar to KStar, not sure how real, but check out the buying volume now, this isn't simply a goreng session
Budget 2021 approve additional 300 million for PPE product purchase for COVID-19 front liner worker.... XDL and Seacera will be the beneficiary counter ....
XDL supply PPE cloth to Seacera and Seacera distribution product of PPE to Government and private hospitals nationwide in Malaysia... seen like sales & revenue will boost this counter on coming soon 2021 years 2 & 3 quarter result announcement
hoowk77, go check XDL forum on KLSE Screener's website and read the comments there, that's why i said not sure real or not, but another person there comment there's information in the recently posted report about PPE distribution, i did receive the audit report in CD form last week from XDL ( the one they send to stockholders ) , but didn't check it yet, anyone else received the CD can clarify here ? i am wondering why suddenly movement today, and it's definitely not goreng, accumulation is on the higher side, surely there's some insider news leaked
Some of u so negative minded. U can't make money if the shares price go down right. U are here because u want return from your investment... if not take a hide. Iam supporting the company in a very small way like u all. Lets do it together. Correct me if iam wrong but I think xdl is one of a good company with potential.
Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.
-----------
US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.
Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.
The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.
Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.
But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
WSP88
572 posts
Posted by WSP88 > 2020-11-07 12:26 | Report Abuse
If you looking good of the company prospect just buy and hold it waiting big wave come and surf together. If not please leaving the counter and keep your money to buy real toilet paper at supermarket. Haha...